Search for: "Janssen Pharmaceuticals Inc." Results 101 - 120 of 247
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Aug 2020, 9:06 am by Clay Hodges
Food and Drug Administration (FDA), and what its makers, Janssen Pharmaceuticals, Inc. [read post]
4 Feb 2015, 1:43 pm
These lawsuits also claim that Bayer AG and Janssen Pharmaceuticals Inc., a part of the Johnson & Johnson Company failed to warn doctors and their patients that Xarelto has no antidote to reverse bleeding should significant bleeding events occur in patients. [read post]
9 Jun 2014, 4:51 am by Robert Kreisman
Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. was the direct manufacturer maker of the Risperdal drug. [read post]
13 Jul 2012, 8:02 pm by Patent Docs
Griem, Jr. of Loeb & Loeb; Patricia Clarke Lukens, Vice President, Law at Janssen Pharmaceuticals, Inc.; and Michael Perry of the Health Care Division at the Federal Trade Commission will analyze the existing case law and pending cases and legislation, review recent trends in settlements reported to the Federal Trade Commission, and discuss in practical terms how this issue affects the conduct and resolution... [read post]
23 Feb 2016, 1:53 am
Mark has some ideas about that.* Of Mice and Men: Regeneron v KymabAs David's post on Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor [2016] EWHC 87 (Pat) clearly shows, mice have a very special relation with patent case law. [read post]
21 Jun 2011, 6:00 am by Mark Zamora
Ortho-McNeil-Janssen Pharmaceuticals Inc. announced that the lot of about 16,000 bottles of 3-milligram Risperdal tablets was shipped out anywhere from August, 2010  and February, 2011. [read post]
29 Apr 2010, 1:26 pm
The settlement arose from two whistleblower cases filed under federal and state False Claims Acts, alleging that Otho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, Inc., improperly marketed Topamax for psychiatric uses, when it was only FDA-approved to treat epilepsy. [read post]
29 Apr 2010, 1:26 pm
The settlement arose from two whistleblower cases filed under federal and state False Claims Acts, alleging that Otho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, Inc., improperly marketed Topamax for psychiatric uses, when it was only FDA-approved to treat epilepsy. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
18 Jun 2012, 5:57 pm by Chad J. Galvin
Omnicare is currently a central player in the ongoing investigation by the Justice Department into how Johnson & Johnson’s Janssen Pharmaceuticals unit pushed the antipsychotic drug Risperdal to nursing home patients, many of whom did not have schizophrenia or bi-polar disease, which are the only ailments for which Risperdal is approved by the FDA. [read post]
8 Sep 2014, 12:00 am by David Jensen
Last month, the firm announced it had received $20 million (see here and here) from Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. [read post]
25 May 2010, 7:54 am by Ed Wallis
” As a result, “Ortho-McNeil Pharmaceutical LLC will pay a $6.14 million criminal fine after pleading guilty…to one count of misdemeanor violation of the Food, Drug and Cosmetic Act for promoting Topamax for unproved uses,” while “its holding company, Titusville, NJ-based Ortho-McNeil-Janssen Pharmaceuticals Inc., will pay $75.37 million to resolve civil allegations under the False Claims Act. [read post]